Lukas Scheipner, Reha-Baris Incesu, Simone Morra, Andrea Baudo, Anis Assad, Letizia Maria Ippolita Jannello, Carolin Siech, Mario de Angelis, Francesco Barletta, Zhe Tian, Fred Saad, Shahrokh F Shariat, Alberto Briganti, Felix K H Chun, Derya Tilki, Nicola Longo, Luca Carmignani, Ottavio De Cobelli, Sascha Ahyai, Pierre I Karakiewicz
BACKGROUND: Data regarding North-American incidental (cT1a/b) prostate cancer (PCa) patients is scarce. To address this, incidental PCa characteristics (age, PSA values at diagnosis, Gleason score [GS]), subsequent treatment and cancer-specific survival (CSS) rates were explored. METHODS: Incidental PCa patients were identified within the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015). Descriptive statistics, annual percentage changes (EAPC), Kaplan-Meier estimates, as well as Cox regression models were used...
October 23, 2023: Prostate Cancer and Prostatic Diseases